Výsledky vyhledávání

How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis

Autor: Aino Siltari, Ragnar Lönnerbro, Karl Pang, Kirill Shiranov, Alex Asiimwe, Susan Evans-Axelsson, Billy Franks, Amit Kiran, Teemu J. Murtola, Jack Schalken, Carl Steinbeisser, Anders Bjartell, Anssi Auvinen, J. N’Dow, E.J. Smith, R. Shepherd, M. Ribal, N. Mottet, L. Moris, M. Lardas, P-P. Willemse, G. Gandaglia, R. Campi, Rossella Nicoletti, M. Gacci, A. Briganti, M.M. Ratti, E. Alleva, L. Leardini, E.S. Sisca, R. Bangma, M. Roobol, S. Remmers, D. Tilki, T. Visakorpi, K. Talala, T. Tammela, M. van Hemelrijck, K. Bayer, S. Lejeune, S. Byrne, L. Fialho, P. Palaiologou B. De Meulder, C. Auffray, A. Hijazy, S. Power, N. Zounemat Kermani, K. van Bochove, M. Kalafati, M. Moinat, E. Voss, D. Horgan, L. Fullwood, M. Holtorf, D. Lancet, G. Bernstein, I. Omar, S. MacLennan, S. Maclennan, S. Tripathee, M. Wirth, M. Froehner, B. Brenner, A. Borkowetz, C. Thomas, F. Horn, K. Reiche, M. Kreux, A. Josefsson, D. Gasi Tandefekt, J. Hugosson, H. Huisman, J. Schalken, T. Hofmacher, P. Lindgren, E. Andersson, A. Fridhammar, J. Zong, J-E. Butler-Ransohoff, R. Herrera, M. Maass, P. Torremante, M.D. Voss, Z. Devecseri, T. Abbott, C. Dau, K. Papineni, R. Snijder, M. Lambrecht, R. Wolfinger, S. Rogiers, A. Servan, L. Antoni, K. Pacoe, P. Robinson, B. Jaton, D. Bakkard, H. Turunen, O. Kilkku, P. Pohjanjousi, O. Voima, L. Nevalaita, C. Reich, S. Araujo, E. Longden-Chapman, D. Burke, P. Agapow, S. Derkits, M. Licour, C. McCrea, S. Payne, A. Yong, L. Thompson, S. Le Mare, M Bussmann, D. Kotik

Publikováno v: Clinical Genitourinary Cancer, 21, 2, pp. 316.e1-316.e11
Clinical Genitourinary Cancer, 21, 316.e1-316.e11

Contains fulltext : 291547.pdf (Publisher’s version ) (Open Access) OBJECTIVES: Genome-wide association studies have revealed over 200 genetic susceptibility loci for prostate cancer (PCa). By combining them, polygenic risk scores (PRS) can be gene

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aebe650dd619575ff9d0e1f7617b2c01
https://hdl.handle.net/2066/291547

Zobrazit plný text záznamu

Interference characterisation of a commercial Joule-Thomson cooler to be used in a SQUID-based foetal heart monitor

Autor: M. R. Bangma, H.J. Holland, A.P. Rijpma, H. A. Reincke, Horst Rogalla, E.G. de Vries, H.J.M. ter Brake

Publikováno v: Cryogenics, 41(9), 657-663. Elsevier

At the University of Twente, a foetal heart monitor based on a high-TC SQUID magnetometer system is under development. The purpose of this system is to measure a foetal heart signal in a clinical environment. For cooling a first demonstrator version,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ebb299591d84e72693cb61533084585
https://research.tue.nl/nl/publications/388bbcaa-ac27-4dbc-b6a4-46c2a965b378

Zobrazit plný text záznamu

Cryogenic Aspects of a Fetal Heart Monitor Based on High-Tc Squids

Autor: M. R. Bangma, Horst Rogalla, A.P. Rijpma, M.J. Peters, H.J.M. ter Brake

Publikováno v: Advances in Cryogenic Engineering ISBN: 9781461368922

A high-Tc SQUID-based magnetometer system for measuring fetal heart activity in standard clinical environments is the goal of the so-called FHARMON project. To lower the threshold for the application of this fetal heart monitor, it should be low-cost

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa0f2c2fdb435b6fb3a0d79cb1def3a8
https://doi.org/10.1007/978-1-4615-4215-5_85

Zobrazit plný text záznamu

EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

Autor: Niall F. Davis, Muhammad Imran Omar, Alberto Briganti, Olivier Rouvière, James N'Dow, Ann Henry, Brett Cox, James W.F. Catto, Derya Tilki, Christopher J.D. Wallis, Maurizio Colecchia, Silke Gillessen, Steven MacLennan, Murali Varma, Thomas Van den Broeck, Philip Cornford, Susanne Vahr Lauridsen, J.P. Michiel Sedelaar, Nicola Fossati, Michael Lardas, Gemma Sancho Pardo, Paolo Dell'Oglio, André Deschamps, Nicolas Mottet, Lisa Moris, Marcus G. Cumberbatch, Thomas Wiegel, Raphaële Renard-Penna, Fabio Zattoni, James Donaldson, Phillip D. Stricker, Matthew Liew, Ivo G. Schoots, Stefano Fanti, Theodorus H. van der Kwast, Geert J.L.H. van Leenders, Nikolaos Grivas, Monique J. Roobol, Erik Briers, Hendrik Van Poppel, Karin Plass, Jeff Davies, Jonathan Richenberg, Maria De Santis, Jacques Irani, Daniel W. Lin, Shin Egawa, Tobias Gross, Peter Paul M. Willemse, Roderick C.N. van den Bergh, Alberto Bossi, Henk G. van der Poel, Chris H. Bangma, Maria J. Ribal, Giorgio Gandaglia, Alexandre Ingels, Karl H. Pang, Morgan Rouprêt, Robert Shepherd, Jeremy Grummet, Thomas B. Lam, Malcolm David Mason, Catherine Paterson, Karel Tim Buddingh, Christian D. Fankhauser, Ruud Baanders, Anders Bjartell, Philippe D. Violette, Karen Wilkinson

Publikováno v: EUROPEAN UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
European Urology, 76(6), 790. Elsevier
European Urology, 76(6), 790-813. Elsevier
European Urology, 76, 6, pp. 790-813
European Urology, 76, 790-813

Background: There is uncertainty in deferred active treatment (DAT) programmes, regarding patient selection, follow-up and monitoring, reclassification, and which outcome measures should be prioritised. Objective: To develop consensus statements for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b318ebcecc6ba380a056dacd7ce84ac8
https://dspace.library.uu.nl/handle/1874/390537

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání